fda

FDA launches new pilot program to crack down on unapproved opioids sold online

June 9, 2020
Manufacturing and Production FDA, opiod crisis, opioids

The FDA is collaborating with the National Telecommunications and Information Administration (NTIA) to launch a pilot program to reduce the …

astrazeneca_sign_sky

AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients

June 8, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma

AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.

nhs_hospit

Two-thirds of Britons with common life-threatening conditions have been denied care during pandemic

June 8, 2020
Sales and Marketing COVID, COVID-19, NHS, NHS England, coronavirus, pandemic

Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …

US supply of Gilead’s remdesivir expected to run out by the end of June

June 8, 2020
Sales and Marketing

The US government will run out of their current supply of Gilead’s remdsivir by the end of the month, the …

Coronavirus pandemic puts UK’s post-Brexit drug stockpile at risk

June 8, 2020
Sales and Marketing COVID-19, coronavirus, drugs

The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the …

stacey

Stacey Coen appointed Senior Vice President and Chief Business Officer at ImmunoGen

June 5, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunoGen have appointed Stacey Coen as their new Senior Vice President and Chief Business Officer. She joins the company from …

remdesivir_ulrich_perrey

Australian Taskforce recommends Gilead’s remdesivir for routine use in the country’s COVID-19 patients

June 5, 2020
Medical Communications, Sales and Marketing Australia, COVID-19, Gilead, coronavirus, remdesivir

Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …

people

British COVID-19 test-and-trace system will not be fully operational until September, despite it launching last month

June 5, 2020
Medical Communications COVID-19, NHS, coronavirus

The NHS COVID-19 test-and-trace system will not be fully operational until September or October, leaked emails from personnel involved with …

black_market

The Lancet retracts paper that highlighted the dangers of taking hydroxychloroquine

June 5, 2020
Medical Communications COVID-19, Lancet, hydroxychloroquine

The Lancet has retracted a paper that claimed to show that people who took hydroxychloroquine to treat COVID-19 had a …

astrazeneca_building_white

AstraZeneca announces new partnerships to deliver two billion COVID-19 vaccine doses, with focus on developing countries

June 5, 2020
Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, Vaccine, coronavirus

As efforts to make an effective vaccine against COVID-19 available around the world continue to gather pace, AstraZeneca has revealed …

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

June 5, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …

novartis_outside_1

Novartis’ Cosentyx hits primary goal in Phase 3 non-radiographic axial spondyloarthritis study

June 4, 2020
Research and Development Cosentyx, Novartis, axial spondyloarthritis

New Phase 3 data has been released on the efficacy of Novartis’ interleukin (IL)-17A inhibitor Cosentyx (secukinumab), showing that the …

rose_buddy

Trump’s Operation Warp Speed selects Pfizer, Merck, AstraZeneca and Moderna as vaccine finalists

June 4, 2020
Business Services COVID-19, Operation Warp Speed, Trump, coronavirus

The Trump administration has selected the finalists for the COVID-19 vaccine it is seeking to make widely available by the …

janssen_latest_logo_on_sign_closer

Janssen’s Tremfya shows skin clearance benefit for psoriatic arthritis patients in two Phase 3 studies

June 4, 2020
Research and Development Janssen, Tremfya, psoriatic arthritis

Janssen has revealed data from two Phase 3 trials for Tremfya (guselkumab), showing improvement in skin clearance and symptoms in …

fitbitstand

Fitbit’s Flow ventilator receives FDA emergency approval

June 4, 2020
Business Services COVID-19, coronavirus, ventalitor

The FDA has granted emergency approval for Fitbit’s ‘Fitbit Flow’ ventilator, a low cost piece of equipment to help fight …

black_market

Hydroxychloroquine does not work as a preventative against COVID-19, new study finds

June 4, 2020
Business Services COVID-19, coronavirus, hydroxychloroquine

The malaria drug hydroxychloroquine does not protect people from COVID-19, according to a new study led by researchers at the …

remdesivir_ulrich_perrey

India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020
Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …

chloroquine

Lancet expresses concern over published hydroxychloroquine and chloroquine paper

June 3, 2020
Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine

The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …

fda

The Association of American Physicians & Surgeons sue FDA to end restrictions on hydroxychloroquine, despite evidence it can be life threatening

June 3, 2020
Research and Development AAPS, COVID-19, coronaviryus

The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access …

The Gateway to Local Adoption Series

Latest content